Washington's pilot program will allow Medicare coverage for CBD, enhancing access to alternative therapies while raising concerns on product safety and regulatory standards.

CMS proposes Medicare coverage for federally and state-legal CBD products, highlighting evolving regulatory approaches amid clinical evidence and hemp legislation conflicts.

New budget bill cuts nearly $1 trillion from Medicaid, introducing work requirements and reducing coverage for chronic pain patients. States face complex implementation challenges impacting healthcare access and insurance markets.